128 related articles for article (PubMed ID: 28633307)
1. Discussion: The role, position, and function of the FDA-The past, present, and future.
Fleming TR; Demets DL; McShane LM
Biostatistics; 2017 Jul; 18(3):417-421. PubMed ID: 28633307
[No Abstract] [Full Text] [Related]
2. Discussion: The FDA is Unprepared for Personalized Medicine.
Tabarrok A
Biostatistics; 2017 Jul; 18(3):403-404. PubMed ID: 28633317
[No Abstract] [Full Text] [Related]
3. FDA dependence on drug industry.
Lawson GW
J Natl Med Assoc; 2005 Jul; 97(7):1039-40. PubMed ID: 16080677
[No Abstract] [Full Text] [Related]
4. Model-Informed Drug Development: A Regulatory Perspective on Progress.
Zhu H; Huang SM; Madabushi R; Strauss DG; Wang Y; Zineh I
Clin Pharmacol Ther; 2019 Jul; 106(1):91-93. PubMed ID: 31162631
[No Abstract] [Full Text] [Related]
5. Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
Lurie P
MedGenMed; 2006 Oct; 8(4):22. PubMed ID: 17415305
[No Abstract] [Full Text] [Related]
6. Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.
Issa AM; Thorogood A; Joly Y; Knoppers BM
Genet Med; 2019 Mar; 21(3):542-544. PubMed ID: 29988078
[No Abstract] [Full Text] [Related]
7. The voices of patients and families must be heard.
Schachter SC
Epilepsy Behav; 2019 May; 94():307. PubMed ID: 30910396
[No Abstract] [Full Text] [Related]
8. Olestra and the FDA.
Blackburn H
N Engl J Med; 1996 Apr; 334(15):984-6. PubMed ID: 8596603
[No Abstract] [Full Text] [Related]
9. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
Steinbrook R
N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
[No Abstract] [Full Text] [Related]
10. Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees.
Graham SS; Card DJ; Ahn S; Kim SY; Kessler MM; Olson MK
Ann Intern Med; 2016 Oct; 165(8):606-607. PubMed ID: 27750309
[No Abstract] [Full Text] [Related]
11. The FDA: A tough tonic.
Wadman M
Nature; 2009 Nov; 462(7272):406-7. PubMed ID: 19940894
[No Abstract] [Full Text] [Related]
12. Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
Loomba R; Ratziu V; Harrison SA;
Gastroenterology; 2022 Mar; 162(3):680-688. PubMed ID: 34822801
[No Abstract] [Full Text] [Related]
13. Former FDA commissioner is fined 90,000 dollars for failing to disclose conflicts of interest.
Tanne JH
BMJ; 2007 Mar; 334(7592):492. PubMed ID: 17347206
[No Abstract] [Full Text] [Related]
14. Keeping science on top in drug evaluation.
Avorn J
N Engl J Med; 2007 Aug; 357(7):633-5. PubMed ID: 17699813
[No Abstract] [Full Text] [Related]
15. The US Food and Drug Administration's Model-Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact.
Madabushi R; Benjamin JM; Grewal R; Pacanowski MA; Strauss DG; Wang Y; Zhu H; Zineh I
Clin Pharmacol Ther; 2019 Jul; 106(1):74-78. PubMed ID: 31081932
[No Abstract] [Full Text] [Related]
16. Politics could hamper FDA reform.
Fox JL
Biotechnology (N Y); 1995 Nov; 13(11):1156. PubMed ID: 9678917
[No Abstract] [Full Text] [Related]
17. In need of rehab.
Nature; 2005 Oct; 437(7060):789-90. PubMed ID: 16208322
[No Abstract] [Full Text] [Related]
18. Vote of confidence for FDA advisory committees, but conflict of interest questions remain.
Marwick C
JAMA; 1992 Dec 23-30; 268(24):3417. PubMed ID: 1334160
[No Abstract] [Full Text] [Related]
19. Proposed FDA conflict-of-interest guidelines get lukewarm reception.
Finkelstein JB
J Natl Cancer Inst; 2007 May; 99(10):747-8. PubMed ID: 17505067
[No Abstract] [Full Text] [Related]
20. Proceedings of a Workshop: US Food and Drug Administration-International Society of Pharmacometrics Model-Informed Drug Development in Oncology.
Bruno R; Jin JY; Maxfield K; Milligan L; Liu C; Wang Y; McKee AE; Zineh I
Clin Pharmacol Ther; 2019 Jul; 106(1):81-83. PubMed ID: 30951201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
